Literature DB >> 2974767

Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations.

R G Malia1, M Greaves, L M Rowlands, A C Lawrence, A Hume, N R Rowell, J Moult, C M Holt, N Lindsey, P Hughes.   

Abstract

Anticardiolipin antibodies of IgG/IgM class were detected in seven of 28 patients with systemic sclerosis including five of 16 patients severely affected by extensive visceral disease. This severely affected sub-group also showed significant elevations of plasma levels of von Willebrand factor antigen in 10 cases and serum C1q binding activity in seven cases respectively. This triple association raises the possibility that multiple immunological mechanisms are involved in the pathogenesis of systemic sclerosis and its vascular lesions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974767      PMCID: PMC1541778     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Scleroderma and its relationship to the "collagenoses": dermatomyositis, lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome.

Authors:  D L TUFFANELLI
Journal:  Am J Med Sci       Date:  1962-02       Impact factor: 2.378

2.  Cardiopulmonary manifestations of progressive systemic sclerosis: associations with circulating immune complexes and fluorescent antinuclear antibodies.

Authors:  E Pisko; K Gallup; R Turner; M Parker; A M Nomeir; J Box; J Davis; P Box; H Rothberger
Journal:  Arthritis Rheum       Date:  1979-05

3.  Factor VIII related antigen: an improved enzyme immunoassay.

Authors:  P E Short; C E Williams; A M Picken; F G Hill
Journal:  Med Lab Sci       Date:  1982-10

4.  "Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation.

Authors:  L O Carreras; J G Vermylen
Journal:  Thromb Haemost       Date:  1982-08-24       Impact factor: 5.249

5.  Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis.

Authors:  R M Bernstein; J C Steigerwald; E M Tan
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

6.  Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders.

Authors:  H R Maricq; E C LeRoy; W A D'Angelo; T A Medsger; G P Rodnan; G C Sharp; J F Wolfe
Journal:  Arthritis Rheum       Date:  1980-02

7.  Platelet activation, fibrinolytic activity and circulating immune complexes in Raynaud's phenomenon.

Authors:  C G Kallenberg; E Vellenga; A A Wouda; T H The
Journal:  J Rheumatol       Date:  1982 Nov-Dec       Impact factor: 4.666

8.  Elevation of platelet factor four in acute myocardial infarction: measurement by radioimmunoassay.

Authors:  R I Handin; M McDonough; M Lesch
Journal:  J Lab Clin Med       Date:  1978-02

9.  Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenon.

Authors:  J van der Maulen; A A Wouda; E Mandema; T H The
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

Review 10.  Vascular disease in progressive systemic sclerosis (scleroderma).

Authors:  W L Norton; J M Nardo
Journal:  Ann Intern Med       Date:  1970-08       Impact factor: 25.391

View more
  16 in total

Review 1.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

2.  Systemic sclerosis sine scleroderma associated with antiphospholipid syndrome.

Authors:  Pollyanna d'Ávila Leite; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2010-04-09       Impact factor: 2.631

3.  Clinical setting of patients with systemic sclerosis by serum autoantibodies.

Authors:  U Picillo; S Migliaresi; M R Marcialis; A M Ferruzzi; G Tirri
Journal:  Clin Rheumatol       Date:  1997-06       Impact factor: 2.980

4.  Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis.

Authors:  C M Holt; N Lindsey; J Moult; R G Malia; M Greaves; A Hume; N R Rowell; P Hughes
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

5.  Recurrent thrombosis and anticardiolipin antibodies associated with adenocarcinoma of the lung.

Authors:  M N Shaukat; P Hughes
Journal:  Postgrad Med J       Date:  1990-04       Impact factor: 2.401

6.  C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus.

Authors:  G Wild; J Watkins; A M Ward; P Hughes; A Hume; N R Rowell
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

7.  Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study.

Authors:  L Naldi; F Locati; L Marchesi; S Cortelazzo; G Finazzi; M Galli; A Brevi; T Cainelli; T Barbui
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

Review 8.  Anti-phospholipid syndrome leading to digital ischaemia and rare organ complications in systemic sclerosis and related disorders.

Authors:  Saion Chatterjee; John D Pauling
Journal:  Clin Rheumatol       Date:  2020-09-21       Impact factor: 2.980

Review 9.  Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis.

Authors:  Alfred Grassegger; Gabriela Pohla-Gubo; Margret Frauscher; Helmut Hintner
Journal:  Wien Med Wochenschr       Date:  2008

10.  Clinical significance of antiphospholipid antibodies in Indian scleroderma patients.

Authors:  R Gupta; M M Thabah; S Gupta; S Shankar; A Kumar
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.